8-K filing — PMV Pharmaceuticals, Inc. (PMVP)
Filed: 2026-08-14 AccNo: 0001193125-26-350445 Size: 366 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
PMV Pharma Q2 EPS $(0.34) Beats $(0.39) Estimate
PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.39) by 12.82 percent. This is a 17.07 percent increase over losses of $(0.41) per share from the
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 14, 2026, 12:12 PM
- Checked
- Aug 14, 2026, 12:12 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading